Delineation of the peptide binding site of the human galanin receptor.

AUTOR(ES)

Kask, K

RESUMO

Galanin, a neuroendocrine peptide of 29 amino acids, binds to Gi/Go-coupled receptors to trigger cellular responses. To determine which amino acids of the recently cloned seven-transmembrane domain-type human galanin receptor are involved in the high-affinity binding of the endogenous peptide ligand, we performed a mutagenesis study. Mutation of the His264 or His267 of transmembrane domain VI to alanine, or of Phe282 of transmembrane domain VII to glycine, results in an apparent loss of galanin binding. The substitution of Glu271 to serine in the extracellular loop III of the receptor causes a 12-fold loss in affinity for galanin. We combined the mutagenesis results with data on the pharmacophores (Trp2, Tyr9) of galanin and with molecular modelling of the receptor using bacteriorhodopsin as a model. Based on these studies, we propose a binding site model for the endogenous peptide ligand in the galanin receptor where the N-terminus of galanin hydrogen bonds with Glu271 of the receptor, Trp2 of galanin interacts with the Zn2+ sensitive pair of His264 and His267 of transmembrane domain VI, and Tyr9 of galanin interacts with Phe282 of transmembrane domain VII, while the C-terminus of galanin is pointing towards the N-terminus of th

Documentos Relacionados

• Molecular cloning of a functional human galanin receptor.
• N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor.
• The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor.
• Cloning and expression of the human vasoactive intestinal peptide receptor.
• Molecular dissection of the agonist binding site of an AMPA receptor.